TLR4 and bronchiolitis: We propose that targeting the binding of TLR-4 by F protein or even the associated use of DNase could potentially lead to novel therapeutic approaches to help control RSV-induced inflammatory consequences and pathology of viral bronchiolitis, which has a major disease burden among infants, worldwide.